
The scoping review evaluated fluorescent markers used for intraoperative visualization of head and neck squamous cell carcinoma (HNSCC). Among 5776 identified records, 65 studies were included. Indocyanine green (ICG), toluidine blue, IRDye800CW-labelled antibodies, and 5-aminolevulinic acid (5-ALA) were the most utilized markers. While ICG and toluidine blue showed limited specificity, targeted derivatives and fluorescently labeled antibodies like cetuximab-IRDye800CW are promising. 5-ALA showed utility but posed risks of photosensitivity. Larger cohort studies are required to determine the optimal marker.
Like
Save
Share